Ambu A/S (OTCMKTS:AMBBY) Shares Down 2.2% – Here’s What Happened

Ambu A/S (OTCMKTS:AMBBY) shares were down 2.2% during trading on Wednesday . The stock traded as low as $15.45 and last traded at $15.45. Approximately 500 shares traded hands during mid-day trading, an increase of 71% from the average daily volume of 293 shares. The stock had previously closed at $15.80.

Ambu A/S Price Performance

The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.51 and a current ratio of 2.52. The firm has a 50 day simple moving average of $18.10 and a two-hundred day simple moving average of $19.06. The stock has a market cap of $3.63 billion and a P/E ratio of 128.75.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings data on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. The business had revenue of $199.56 million for the quarter. Ambu A/S had a net margin of 4.30% and a return on equity of 4.09%.

Ambu A/S Announces Dividend

The business also recently declared a dividend, which will be paid on Monday, December 23rd. Stockholders of record on Friday, December 6th will be paid a $0.0557 dividend. The ex-dividend date of this dividend is Friday, December 6th.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.